Fludalym is an anti-cancer drug.
Fludalym is used to treat chronic B-cell lymphocytic leukaemia (B-CLL) in patients with sufficient healthy blood cell production. This is a type of cancer of white blood cells (the cells are called lymphocytes).
First treatment for chronic lymphocytic leukaemia with Fludalym should only be started in patients with advanced disease having disease related symptoms or evidence of disease progression.